170 related articles for article (PubMed ID: 31641350)
1. Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study.
Qiao Y; Wang Z; Han J; Li G
Int J Endocrinol; 2019; 2019():1438723. PubMed ID: 31641350
[TBL] [Abstract][Full Text] [Related]
2. Corroboration of Height Velocity Prediction Markers for rhGH With an Oral GH Secretagogue Treatment in Children With GHD.
Blum WF; Bright GM; Do MT; McKew JC; Chen H; Thorner MO
J Endocr Soc; 2021 Jun; 5(6):bvab029. PubMed ID: 33982678
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetic and pharmacodynamic properties and short-term outcome of a novel once-weekly PEGylated recombinant human growth hormone for children with growth hormone deficiency.
Liang Y; Zhang C; Wei H; Du H; Zhang G; Yang Y; Zhang H; Gong H; Li P; Song F; Xu Z; He R; Zhou W; Zheng H; Sun L; Luo X
Front Endocrinol (Lausanne); 2022; 13():922304. PubMed ID: 36034448
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency.
Du H; Wu D; Yi P; Bai X; Luo Y; Yang H; Chen S; Pan H; Zhu H
J Pediatr Endocrinol Metab; 2022 Apr; 35(4):511-517. PubMed ID: 35245011
[TBL] [Abstract][Full Text] [Related]
6. Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies.
Luo X; Hou L; Liang L; Dong G; Shen S; Zhao Z; Gong CX; Li Y; Du ML; Su Z; Du H; Yan C
Eur J Endocrinol; 2017 Aug; 177(2):195-205. PubMed ID: 28566441
[TBL] [Abstract][Full Text] [Related]
7. Reduced Effectiveness and Comparable Safety in Biweekly
Sun C; Lu B; Liu Y; Zhang Y; Wei H; Hu X; Hu P; Zhao Q; Liu Y; Ye K; Wang K; Gu Z; Liu Z; Ye J; Zhang H; Zhu H; Jiang Z; Liu Y; Wan N; Yan C; Yin J; Ying L; Huang F; Yin Q; Xi L; Luo F; Cheng R
Front Endocrinol (Lausanne); 2021; 12():779365. PubMed ID: 34899612
[TBL] [Abstract][Full Text] [Related]
8. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
Grumbach MM; Bin-Abbas BS; Kaplan SL
Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
Deal CL; Steelman J; Vlachopapadopoulou E; Stawerska R; Silverman LA; Phillip M; Kim HS; Ko C; Malievskiy O; Cara JF; Roland CL; Taylor CT; Valluri SR; Wajnrajch MP; Pastrak A; Miller BS
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2717-e2728. PubMed ID: 35405011
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.
Hwang JS; Lee HS; Chung WY; Han HS; Jin DK; Kim HS; Ko CW; Lee BC; Lee DY; Lee KH; Shin JH; Suh BK; Yoo HW; Ji HJ; Lee JH; Bae YJ; Kim DH; Yang SW
Eur J Endocrinol; 2013 Aug; 169(2):179-85. PubMed ID: 23682096
[TBL] [Abstract][Full Text] [Related]
11. Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study.
Jiang Z; Chen X; Dong G; Lou Y; Zhang J; Cheng X; Pan J; Liao W; Wu J; Huang X; Jin X; Liu D; Zeng T; Zhu S; Dong Q; Luo X; Lan D; Cao L; Zhang X; Liu J; Dai M; Zhang M; Liu L; Dong J; Zhao D; Ni S; Fu J
Front Pharmacol; 2022; 13():955809. PubMed ID: 36034802
[No Abstract] [Full Text] [Related]
12. Long-term Pegylated GH for Children With GH Deficiency: A Large, Prospective, Real-world Study.
Hou L; Huang K; Gong C; Luo F; Wei H; Liang L; Du H; Zhang J; Zhong Y; Chen R; Chen X; Pan J; Jin X; Zeng T; Liao W; Liu D; Lan D; Zhu S; Dong Z; Ma H; Yang Y; Xiong F; Lu P; Cheng S; Gu X; Jin R; Liu Y; Wu J; Xu X; Chen L; Dong Q; Pan H; Su Z; Liu L; Luo X; Ni S; Chen Z; Hu Y; Wang C; Liu J; Liu L; Lu B; Wang X; Wang Y; Yang F; Zhang M; Cao L; Liu G; Yao H; Zhan Y; Dai M; Li G; Li L; Liu Y; Wang K; Xiao Y; Zhang X; Dong J; Gu Z; Ying L; Huang F; Liu Y; Liu Z; Ye J; Zhao D; Hu X; Jiang Z; Ye K; Zhu H; Chen S; Chen X; Wan N; Xu Z; Yin Q; Zhang H; Huang X; Yin J; Zhang H; Li P; Yin P; Fu J; Luo X
J Clin Endocrinol Metab; 2023 Jul; 108(8):2078-2086. PubMed ID: 36669772
[TBL] [Abstract][Full Text] [Related]
13. Linear growth response to recombinant human growth hormone in children with growth hormone deficiency.
Shih KC; Ho LT; Kuo HF; Chang TC; Liu PC; Chen CK; Tiu CM
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jul; 54(1):7-13. PubMed ID: 8087727
[TBL] [Abstract][Full Text] [Related]
14. Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3.
Sävendahl L; Battelino T; Højby Rasmussen M; Brod M; Saenger P; Horikawa R
J Clin Endocrinol Metab; 2022 Apr; 107(5):1357-1367. PubMed ID: 34964458
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
[TBL] [Abstract][Full Text] [Related]
16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
[No Abstract] [Full Text] [Related]
17. Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
Sävendahl L; Battelino T; Brod M; Højby Rasmussen M; Horikawa R; Juul RV; Saenger P;
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1847-61. PubMed ID: 31917835
[TBL] [Abstract][Full Text] [Related]
18. 24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.
Khadilkar V; Radjuk KA; Bolshova E; Khadgawat R; El Kholy M; Desai M; Peterkova V; Mericq V; Kratzsch J; Siepl EC; Martin D; Lopez P; Ji HJ; Bae YJ; Lee JH; Saenger PH
J Clin Endocrinol Metab; 2014 Jan; 99(1):126-32. PubMed ID: 24170106
[TBL] [Abstract][Full Text] [Related]
19. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
[TBL] [Abstract][Full Text] [Related]
20. Long-term Response to Recombinant Human Growth Hormone Therapy in Indian Children with Growth Hormone Deficiency.
Gahlot M; Goyal A; Singh AKC; Jyotsna VP; Gupta N; Khadgawat R
Indian J Endocrinol Metab; 2019; 23(4):446-451. PubMed ID: 31741904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
